The U.S. Food and Drug Administration (FDA) approved Thursday a new type of prescription pain medication for moderate to ...

The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under ...

A new opioid-free pain medication was approved by the FDA on Thursday, marking a non-addictive alternative for patients.

This milestone marks a breakthrough after unsuccessful attempts to develop painkillers without the addictive potential of ...

Introducing Journavx: the FDA-approved non-opioid, non-addictive drug for acute pain. A major breakthrough in pain medication ...

Dr. Sanjay Gupta said Tuesday that the approval of a new non-opioid pain medication is “a pretty big deal.” “This is a pretty ...

That, he said, is worrying. “My biggest concern is that we have drugs that are demonstrating as effective for acute pain that all of a sudden extrapolate the data to chronic pain,” he said.

On Wednesday, the U.S. Food and Drug Administration approved a new pain management drug which could change the way healthcare ...

“A new non-opioid analgesic therapeutic class for acute pain offers an opportunity to mitigate certain risks associated with ...

The Food and Drug Administration (FDA) has approved Symbravo ® (meloxicam/rizatriptan) for the acute treatment of migraine with or without aura in adults.

“A new non-opioid analgesic therapeutic class for acute pain offers an opportunity to mitigate certain risks associated with using an opioid for pain and provides patients with another treatment ...